PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP)

Q: What does CUSIP 69353Y103 represent in this 13F holders report?

CUSIP 69353Y103 is the security identifier for PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share used to aggregate holder disclosures.

Q: How many institutions held PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share in Q1 2024?

96 institutional investors reported PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share for Q1 2024. Use the holders table for investor-level position and value details.

CUSIP: 69353Y103

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class: Equity / Common Stock, $0.00001 par value per share
Shares outstanding: 53,625,367
Total 13F shares: 42,725,320
Share change: -3,729,529
Total reported value: $72,627,924
Put/Call ratio: 32%
Price per share: $1.70
Number of holders: 96
Value change: -$11,853,919
Number of buys: 48
Number of sells: 39

Quarterly Holders Quick Answers

What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2024
Previous quarter: Q4 2023

Recent filing periods for CUSIP 69353Y103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	12%	6,475,291	$20,073,402	—	31 Dec 2023	13F
JPMORGAN CHASE & CO	13F	Company	7.3%	3,930,340	$12,184,054	—	31 Dec 2023	13F
INTERWEST PARTNERS X LP	3/4/5	10%+ Owner	— class O/S missing	4,502,480	$10,040,531	—	13 Jul 2021	3/4/5
BlackRock Finance, Inc.	13F	Company	6%	3,229,797	$10,012,371	—	31 Dec 2023	13F
ArrowMark Colorado Holdings LLC	13F	Company	5.1%	2,714,143	$8,413,843	—	31 Dec 2023	13F
Euclidean Capital LLC	13F 3/4/5	Company · 10%+ Owner	4.9%	2,627,643	$8,145,693	—	31 Dec 2023	13F 3/4/5
VANGUARD GROUP INC	13F	Company	4.5%	2,405,307	$7,456,451	—	31 Dec 2023	13F
ALKEON CAPITAL MANAGEMENT LLC	13F	Company	4.4%	2,345,361	$7,270,619	—	31 Dec 2023	13F
Woodline Partners LP	13F	Company	3.3%	1,791,553	$5,553,814	—	31 Dec 2023	13F
Verition Fund Management LLC	13F	Company	2.9%	1,580,487	$4,899,510	—	31 Dec 2023	13F
PFM Health Sciences, LP	13F	Company	2.7%	1,473,013	$4,566,340	—	31 Dec 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	2.7%	1,439,841	$4,463,507	—	31 Dec 2023	13F
CITADEL ADVISORS LLC	13F	Company	2.3%	1,230,350	$3,814,085	—	31 Dec 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.6%	860,336	$2,667,318	—	31 Dec 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.5%	802,875	$2,488,912	—	31 Dec 2023	13F
Thilo Schroeder	3/4/5	Director	— class O/S missing	1,101,283	$2,455,861	—	06 Oct 2021	3/4/5
ACADIAN ASSET MANAGEMENT LLC	13F	Company	1.4%	768,449	$2,379,000	—	31 Dec 2023	13F
Point72 Asset Management, L.P.	13F	Company	1.4%	750,153	$2,325,474	—	31 Dec 2023	13F
Ghost Tree Capital, LLC	13F	Company	1.4%	725,000	$2,247,500	—	31 Dec 2023	13F
STATE STREET CORP	13F	Company	1.3%	723,454	$2,242,707	—	31 Dec 2023	13F
FEDERATED HERMES, INC.	13F	Company	1.3%	703,338	$2,180,348	—	31 Dec 2023	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	1.3%	685,985	$2,126,554	—	31 Dec 2023	13F
Vontobel Holding Ltd.	13F	Company	1.3%	685,985	$2,126,554	—	31 Dec 2023	13F
EcoR1 Capital, LLC	13F	Company	1.1%	566,879	$1,757,325	—	31 Dec 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1%	557,471	$1,728,258	—	31 Dec 2023	13F
PERSONAL CFO SOLUTIONS, LLC	13F	Company	1%	550,342	$1,706,060	—	31 Dec 2023	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	1%	550,000	$1,705,000	—	31 Dec 2023	13F
CITIGROUP INC	13F	Company	0.97%	520,607	$1,613,882	—	31 Dec 2023	13F
BARCLAYS PLC	13F	Company	0.96%	517,364	$1,603,829	—	31 Dec 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.8%	429,642	$1,331,890	—	31 Dec 2023	13F
MORGAN STANLEY	13F	Company	0.74%	399,178	$1,237,451	—	31 Dec 2023	13F
NORTHERN TRUST CORP	13F	Company	0.61%	327,224	$1,014,395	—	31 Dec 2023	13F
BAKER BROS. ADVISORS LP	13F	Company	0.6%	322,024	$998,274	—	31 Dec 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.52%	278,701	$863,973	—	31 Dec 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.48%	258,527	$801,434	—	31 Dec 2023	13F
XTX Topco Ltd	13F	Company	0.47%	249,412	$773,177	—	31 Dec 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	0.46%	248,505	$770,365	—	31 Dec 2023	13F
M&T BANK CORP	13F	Company	0.37%	197,682	$612,407	—	31 Dec 2023	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.36%	194,900	$604,190	—	31 Dec 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.35%	188,600	$584,660	—	31 Dec 2023	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.35%	185,123	$573,881	—	31 Dec 2023	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.29%	157,645	$488,699	—	31 Dec 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.29%	152,959	$474,174	—	31 Dec 2023	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.26%	141,788	$439,542	—	31 Dec 2023	13F
UBS Group AG	13F	Company	0.24%	127,868	$396,391	—	31 Dec 2023	13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	0.23%	126,000	$390,600	—	31 Dec 2023	13F
Bank of New York Mellon Corp	13F	Company	0.23%	125,487	$389,010	—	31 Dec 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.23%	125,380	$388,678	—	31 Dec 2023	13F
NEW YORK LIFE INVESTMENT MANAGEMENT LLC	13F	Company	0.14%	72,683	$225,317	—	31 Dec 2023	13F
Assenagon Asset Management S.A.	13F	Company	0.13%	70,814	$219,523	—	31 Dec 2023	13F

Institutional Holders of PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP) as of Q1 2024

As of 31 Mar 2024, PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP) was held by 96 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,725,320 shares. The largest 10 holders included ORBIMED ADVISORS LLC, ArrowMark Colorado Holdings LLC, BlackRock Inc., Euclidean Capital LLC, VANGUARD GROUP INC, ALKEON CAPITAL MANAGEMENT LLC, ACADIAN ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, BANK OF AMERICA CORP /DE/, and BML Capital Management, LLC. This page lists 96 institutional shareholders reporting positions in this security for the Q1 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders

Q1 2024 holders

Holder diff

-1

Investor	Q4 2023 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q4 2023 Value $	Q1 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.